Page 23 - JCTR-10-3
P. 23

Shegena et al. | Journal of Clinical and Translational Research 2024; 10(3): 191-200   197
        Table 4. Factors associated with DTPs among hospitalized HF patients at the MRRH
        Variable                         No DTP, n (%)  DTP, n (%)  COR (95%CI)    P COR    AOR (95% CI)    P AOR
        Age* (years)
         ≤18                               16 (61.5)    10 (38.5)       1           -            1            -
         19 – 59                           34 (70.8)    14 (29.2)  0.66 (0.24 – 1.81)  0.416  0.39 (0.12 – 1.2)  0.099
         ≥60                                11 (25)      33 (75)    4.8 (2.1 – 10.6)  0.003 #  4.1 (1.5 – 10.3)  0.012 #
        Gender*
         Male                              28 (60.8)    18 (39.2)       1           -            1            -
         Female                            33 (45.8)    39 (54.2)  0.54 (0.26 – 1.16)  0.113  2.09 (0.86 – 5.06)  0.102
        Education
         No formal education               23 (43.4)    30 (56.6)  1.3 (0.37 – 4.57)  0.678     N/A          N/A
         Primary                           32 (60.3)    21 (39.7)  0.65 (0.18 – 2.31)  0.512    N/A          N/A
         Secondary and above                6 (50)       6 (50)         1           -            1            -
        Occupation*
         Unemployed                         21 (50)      21 (50)   4.0 (0.41 – 12.8)  0.232  2.73 (0.17 – 20.81)  0.477
         Self-employed                     36 (50.7)    35 (49.3)  3.88 (0.41 – 13.1)  0.235  1.23 (0.10 – 15.47)  0.869
         Formally employed                  4 (80)       1 (20)         1           -            1            -
        Disease status
         New                                28 (50)      28 (50)        1           -            1            -
         Known                             33 (53.2)    29 (46.8)  0.88 (0.43 – 1.8)  0.726     N/A          N/A
        Previous hospital admission*
         Yes                               44 (56.4)    34 (43.6)  1.75 (0.81 – 3.77)  0.154  0.44 (0.17 – 1.15)  0.093
         No                                17 (42.5)    23 (57.5)       1           -            1            -
        Length of hospital stay* (days)
         ≤5                                20 (74.1)    7 (25.9)        1           -            1            -
         6 – 10                            28 (47.4)    31 (52.6)   3.2 (1.2 – 8.6)  0.024 #  1.82 (0.54 – 6.09)  0.332
         ≥11                               13 (40.6)    19 (59.4)   4.1 (1.4 – 10.7)  0.012 #  2.21 (0.59 –8.34)  0.238
        Counseling
         Yes                               55 (51.4)    52 (48.6)       1           -            1            -
         No                                6 (54.5)     5 (45.5)   1.13 (0.33 – 3.9)  0.843     N/A          N/A
        Comorbidity*
         Yes                               45 (48.3)    48 (51.7)  1.89 (0.76 – 4.72)  0.16  2.52 (0.86 – 5.06)  0.094
         No                                 16 (64)      9 (36)         1           -            1            -
        OTC medication use within the past 4 weeks
         Yes                                21 (50)      21 (50)   1.11 (0.52 – 2.36)  0.784    N/A          N/A
         No                                40 (52.6)    36 (47.4)       1           -            1            -
        Herbal use within the past 4 weeks*
         Yes                               22 (42.3)    30 (57.7)  1.97 (0.94 – 3.11)  0.071  1.52 (0.64 – 3.64)  0.344
         No                                39 (59.1)    27 (40.9)       1           -            1            -
        Alcohol use history
         Yes                               18 (54.5)    15 (45.5)  0.85 (0.38 – 1.9)  0.70      N/A          N/A
         No                                43 (50.6)    42 (49.4)       1           -            1            -
        Poly-pharmacy*
         Yes                               35 (46.6)    40 (53.4)  1.75 (0.82 – 3.51)  0.151  2.92 (1.5 – 7.6)  0.029 #
         No                                26 (60.5)    17 (39.5)       1           -            1            -
        Drug–drug interaction
         Yes                               39 (49.4)    40 (50.6)  1.32 (0.62 – 2.8)  0.472     N/A          N/A
         No                                22 (56.4)    17 (43.6)       1           -            -            -
                                                     #
        Note: *Denotes variables with p COR <0.25, selected for further AOR analysis;   p COR/AOR  <0.05; N/A denotes AOR (and p AOR ) not determined for the respective variable. Abbreviations:
        COR: Crude odds ratio; AOR: Adjusted odds ratio: CI: Confidence interval: OTC: Over-the-counter; HF: Heart failure; MRRH: Mbarara Regional Referral Hospital; DTPs: Drug therapy
        problems.




                                              DOI: https://doi.org/10.36922/jctr.23.00137
   18   19   20   21   22   23   24   25   26   27   28